ADMA โ€“ ADMA Biologics Inc. โ€“ 30-Min Bullish Breakout Setup!

40
๐Ÿ“ˆ ๐Ÿš€
๐Ÿ”น Asset: ADMA (NASDAQ)
๐Ÿ”น Timeframe: 30-Min Chart
๐Ÿ”น Setup Type: Trendline Support + Falling Wedge Breakout

๐Ÿ“Š Trade Plan (Long Position)
โœ… Entry Zone: Above $20.30 (breakout confirmation above wedge resistance)
โœ… Stop-Loss (SL): Below $19.72 (below trendline and key structure)

๐ŸŽฏ Take Profit Targets
๐Ÿ“Œ TP1: $20.90 โ€“ Minor resistance & last swing high
๐Ÿ“Œ TP2: $21.72 โ€“ Major resistance / profit-taking zone

๐Ÿ“Š Risk-Reward Ratio Calculation
๐Ÿ“‰ Risk:
$20.30 - $19.72 = $0.58 risk per share

๐Ÿ“ˆ Reward to TP1:
$20.90 - $20.30 = $0.60 (1.03:1 R/R)

๐Ÿ“ˆ Reward to TP2:
$21.72 - $20.30 = $1.42 (2.44:1 R/R)

๐Ÿ” Technical Analysis & Strategy
๐Ÿ“Œ Falling Wedge: Price consolidating with higher lows and lower highs, signaling potential breakout

๐Ÿ“Œ Trendline Support: Strong base holding since March 18th โ€” bullish structure intact

๐Ÿ“Œ Volume Observation: Watch for a pop in volume as confirmation of breakout

๐Ÿ“Œ Yellow Zone: Mid-level area reclaiming previous resistance turned support

โš™๏ธ Trade Execution & Risk Management
๐Ÿ“Š Entry Confirmation: 30-min candle close above $20.30
๐Ÿ“‰ SL Strategy: Place SL below trendline at $19.72
๐Ÿ” Trailing Stop Strategy:
โœ” SL to breakeven at TP1
โœ” Trail above $20.60 toward TP2

๐Ÿ’ฐ Profit Booking Strategy
โœ” Take 50% profit at TP1 = $20.90
โœ” Hold remaining toward TP2 = $21.72
โœ” Raise SL progressively to secure profits

โš ๏ธ Setup Invalid Conditions
โŒ Breakdown below $19.72 invalidates trend and wedge
โŒ Avoid entry without bullish close above wedge

๐Ÿš€ Final Thoughts
โœ” Great trendline support + falling wedge = strong technical confluence
โœ” Breakout from yellow zone can trigger a quick move toward $21+
โœ” Clean, well-structured long setup with 2.4:1 potential R/R

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.